- Home
- KOS vs KROS Comparison
KOS vs KROS Comparison
Compare KOS & KROS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOS
- KROS
- Stock Information
- Founded
- KOS 2003
- KROS 2015
- Country
- KOS United States
- KROS United States
- Employees
- KOS N/A
- KROS N/A
- Industry
- KOS Oil & Gas Production
- KROS Biotechnology: Pharmaceutical Preparations
- Sector
- KOS Energy
- KROS Health Care
- Exchange
- KOS Nasdaq
- KROS Nasdaq
- Market Cap
- KOS 817.4M
- KROS 558.9M
- IPO Year
- KOS 2011
- KROS 2020
- Fundamental
- Price
- KOS $1.88
- KROS $13.37
- Analyst Decision
- KOS Buy
- KROS Buy
- Analyst Count
- KOS 6
- KROS 13
- Target Price
- KOS $4.52
- KROS $20.63
- AVG Volume (30 Days)
- KOS 13.3M
- KROS 637.6K
- Earning Date
- KOS 08-04-2025
- KROS 08-06-2025
- Dividend Yield
- KOS N/A
- KROS N/A
- EPS Growth
- KOS N/A
- KROS N/A
- EPS
- KOS N/A
- KROS 0.11
- Revenue
- KOS $1,546,854,000.00
- KROS $214,713,000.00
- Revenue This Year
- KOS N/A
- KROS $5,006.76
- Revenue Next Year
- KOS $12.42
- KROS N/A
- P/E Ratio
- KOS N/A
- KROS $123.16
- Revenue Growth
- KOS N/A
- KROS 91657.70
- 52 Week Low
- KOS $1.39
- KROS $9.12
- 52 Week High
- KOS $5.97
- KROS $72.37
- Technical
- Relative Strength Index (RSI)
- KOS 48.20
- KROS 42.27
- Support Level
- KOS $2.09
- KROS $13.25
- Resistance Level
- KOS $2.32
- KROS $13.99
- Average True Range (ATR)
- KOS 0.14
- KROS 0.36
- MACD
- KOS -0.04
- KROS -0.06
- Stochastic Oscillator
- KOS 29.60
- KROS 20.75
About KOS Kosmos Energy Ltd. (DE)
Kosmos Energy Ltd is a deepwater exploration and production company focused on meeting the world's growing demand for energy. It has diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America. The Company had operations in four geographic reporting segments: Ghana, Equatorial Guinea, Mauritania/Senegal and the Gulf of America. The majority of revenue is derived from the Ghana segment.
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.